A Rare Case of Monogenic Obesity due to a Novel Variant in the ADCY3 Gene: Challenges in Follow-up and Treatment
Open Access
- 19 October 2023
- journal article
- research article
- Published by Galenos Yayinevi in Journal of Clinical Research in Pediatric Endocrinology
- Vol. 17 (3) , 337-344
Abstract
Adenylate cyclase 3 (ADCY3) gene alterations have been found to be associated with obesity. However, few patients with homozygous mutations have been reported so far, and the follow-up procedure and treatment options have not been clarified. A 10-month-old female presented with increased appetite and weight gain. She was born from a consanguineous marriage. Weight, height, head circumference measurements and standard deviation scores (SDS) were 19 kg (+6.98 SDS), 82 cm (+3.53 SDS), and 49 cm (+3.07 SDS), respectively. Laboratory tests revealed a fasting glucose level of 103 mg/dL (5.7 mmol/L), insulin level of 25.39 µIU/mL, and Homeostatic Model Assessment for Insulin Resistance (HOMA-IR) value of 6.43. Whole-exome sequencing revealed a novel, homozygous c.1102G>A(p.Asp368Asn) variant in ADCY3. Her parents and healthy sister were heterozygous for the variant. At the age of 2.5 years, neurodevelopmental delay was observed. At the age of 3.5 years, the patient's weight, height, and body mass index values were 49.5 kg (+8.16 SDS), 111 cm (+2.59 SDS), and 40.18 kg/m2 (+6.48 SDS), respectively. Signs of Blount's disease and acanthosis nigricans were distinctive, and she had hyperphagia. She was undergoing speech therapy. Homozygous ADCY3 variants may present with early onset, severe obesity, insulin resistance, and neurodevelopmental delay in children. Severe complications may occur even at young ages. More data regarding the follow-up process and treatment of these patients are needed.Keywords
This publication has 28 references indexed in Scilit:
- Genome-wide association study of height-adjusted BMI in childhood identifies functional variant inADCY3Obesity, 2014
- Liraglutide as a Potentially Useful Agent for Regulating Appetite in Diabetic Patients with Hypothalamic Hyperphagia and ObesityInternal Medicine, 2014
- Upregulation of adenylate cyclase 3 (ADCY3) increases the tumorigenic potential of cells by activating the CREB pathwayOncotarget, 2013
- Serum IGF-1 and IGFBP-3 Levels in Healthy Children Between 0 and 6 Years of Age - Original ArticleJournal of Clinical Research in Pediatric Endocrinology, 2011
- Evaluation of the Association between the AC3 Genetic Polymorphisms and Obesity in a Chinese Han PopulationPLOS ONE, 2010
- Insulin Resistance in Obese Children and Adolescents: HOMA-IR Cut-Off Levels in the Prepubertal and Pubertal Periods - Original ArticleJournal of Clinical Research in Pediatric Endocrinology, 2010
- Adult Type 3 Adenylyl Cyclase–Deficient Mice Are ObesePLOS ONE, 2009
- Genetic variation of the adenylyl cyclase 3 (AC3) locus and its influence on type 2 diabetes and obesity susceptibility in Swedish menInternational Journal of Obesity, 2007
- Clinical Spectrum of Obesity and Mutations in the Melanocortin 4 Receptor GeneNew England Journal of Medicine, 2003
- Disruption of the Type III Adenylyl Cyclase Gene Leads to Peripheral and Behavioral Anosmia in Transgenic MiceNeuron, 2000